tm
Seeing Is Believing
tm
Seeing Is Believing
LCTX is currently covered by 1 analysts with an average price target of $9.06. This is a potential upside of $8.04 (788.24%) from yesterday's end of day stock price of $1.02.
Lineage Cell Therapeutics's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of LCTX is 100% BUY.
Highest price target for LCTX is $9, Lowest price target is $9, average price target is $9.
Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 23-Jun-2025. First documented stock forecast 10-Mar-2023.
Currently out of the existing stock ratings of LCTX, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$7.97 (773.79%)
$9
23 days ago
(23-Jun-2025)
0/11 (0%)
$8.04 (837.50%)
What is LCTX (Lineage Cell Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LCTX (Lineage Cell Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LCTX (Lineage Cell Therapeutics)?
Which analyst is the currently most bullish on LCTX (Lineage Cell Therapeutics)?
